investor damages

NuScale Power faces securities lawsuit alleging executives misrepresented partner ENTRA1 Energy's nuclear experience. Lead plaintiff deadline: April 20, 2026.

Rosen Law Firm solicits Gartner investors in class action over alleged false statements about growth targets and contract value projections.

Class action lawsuit filed against FBRT alleging executives made false statements about dividend sustainability between November 2024 and February 2026.

Rosen Law Firm sues monday.com for allegedly concealing decelerating growth and extended sales cycles during a six-month period. Lead plaintiff deadline: May 11, 2026.

Camping World Holdings faces securities class action lawsuit over alleged inventory misstatements. Lead plaintiff deadline: May 11, 2026.

Vital Farms faces class action lawsuit over alleged ERP system misstatements that caused missed earnings targets between May 2025 and February 2026.

Schall Law Firm seeks $RGNX investors for securities fraud class action alleging false statements about RGX-111 candidate, following tumor discovery in trial participant.

Rosen Law Firm urges $ENPH investors to join class action alleging false statements on inventory management and financial prospects. Lead plaintiff deadline: April 20, 2026.

Rosen Law Firm launches class action against ODDITY Tech (NASDAQ: $ODD) for allegedly concealing impact of major advertising partner's algorithm changes on customer acquisition costs.

Rosen Law Firm urges $QURE investors to join securities lawsuit alleging misrepresentation of Pivotal Study design and BLA timeline delays. Lead plaintiff deadline: April 13, 2026.

Rosen Law Firm urges $NKTR investors to join class action lawsuit alleging false statements about REZOLVE-AA trial enrollment protocols caused significant shareholder losses.

Rosen Law Firm files class action against $LU over false statements regarding internal controls and financial reporting. Investors who purchased securities between April 2023 and January 2025 may be eligible.

Class action filed against Apollo Global Management over alleged false statements regarding Jeffrey Epstein business dealings by executives.

Rosen Law Firm recruits lead plaintiffs for securities class action against REGENXBIO over alleged false statements regarding RGX-111 gene therapy trial data. Lead plaintiff deadline: April 14, 2026.

Rosen Law Firm urges $BSX investors to join securities lawsuit alleging false statements about U.S. Electrophysiology segment sustainability. Lead plaintiff deadline: May 4, 2026.

Class action lawsuit filed against $FBRT alleging executives made false statements about dividend sustainability and trust prospects between November 2024 and February 2026.

Rosen Law Firm recruits investors for securities class action against REGENXBIO over alleged RGX-111 gene therapy misstatements. Lead plaintiff deadline: April 14, 2026.

Boston Scientific faces class action over false electrophysiology segment statements. Investors from July 2025–February 2026 may recover damages; lead plaintiff deadline May 4, 2026.

Rosen Law Firm filed a class action lawsuit against Gartner ($IT) alleging false statements about growth targets. Lead plaintiff deadline is May 18, 2026.

$APO investors must act before May 1, 2026 deadline in securities lawsuit alleging executives falsely denied Epstein business relationship.